Results 311 to 320 of about 138,877 (380)

Effects of cannabidiol in alcohol use disorder patients with and without co‐occurring post‐traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof‐of‐concept trials

open access: yesAlcohol, Clinical and Experimental Research, Volume 50, Issue 1, January 2026.
Two small placebo‐controlled trials evaluated the effects of cannabidiol (CBD) in patients with alcohol use disorder (AUD), with and without co‐occurring post‐traumatic stress disorder (PTSD). CBD was rapidly absorbed and generally well tolerated in dosages of up to 1200 mg/day. Both treatment groups showed large reductions in drinking.
Michael P. Bogenschutz   +6 more
wiley   +1 more source

Erosive Lichen Planus With Ocular Involvement: A Case Report. [PDF]

open access: yesAm J Case Rep
Oliani CHP   +7 more
europepmc   +1 more source

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study

open access: yesAllergy, Volume 81, Issue 1, Page 232-247, January 2026.
The aim of the study is to interrogate immunological mechanisms induced by PQ Grass conventional and extended regimens. A short‐course pre‐seasonal subcutaneous injection of PQ Grass is effective in inducing immune tolerance by generating functional blocking antibodies and modulating T cell compartments.
Janice A. Layhadi   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy